High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India

BACKGROUND/AIMS: The data on the risk of tuberculosis (TB) reactivation with infliximab (IFX) in patients with inflammatory bowel disease (IBD) from TB endemic countries, like India, is limited. The risk of TB reactivation on IFX and its predictors in patients with IBD was assessed. METHODS: This re...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Ashish, Kedia, Saurabh, Jain, Saransh, Gupta, Vipin, Bopanna, Sawan, Yadav, Dawesh P, Goyal, Sandeep, Mouli, Venigalla Pratap, Dhingra, Rajan, Makharia, Govind, Ahuja, Vineet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223459/
https://www.ncbi.nlm.nih.gov/pubmed/30301331
http://dx.doi.org/10.5217/ir.2018.00023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223459/
https://www.ncbi.nlm.nih.gov/pubmed/30301331
http://dx.doi.org/10.5217/ir.2018.00023

Ejemplares similares